Sphingoloids are found in the extracellular spaces of the stratum corneum, where they play a critical role in strengthening the barrier function of the skin, promoting moisture retention and increasing elasticity of the skin.
Better barrier function
The specific technology consists of a novel lamellar lipid topically delivered through a custom formulation system, which clinical studies demonstrated significantly better barrier function with substantial improvement in moisture retention when compared to commercially available sphingolipid compounds.
As part of this exclusive licensing arrangement, Ei has been granted options on several related technologies in various stages of development.
"This investment in intellectual property demonstrates Ei's mission to offer our customers value beyond typical development and manufacturing capability," said Michael Kane, CEO, Ei.
"Our customers have asked for - and we are responding with - unique, efficacious and highly protected ways to innovate for their customers and enhance the value of their brands."
Skin care focus
Primarily strong in the pharmaceutical market, the Charlotte-based company has turned its focus to skin care with its latest license.
"We are pleased to have been able to partner Ei with a unique group of specialists to develop this important advancement in skin care," said David Yurkerwich, vice president at Charles River Associates, the consulting firm which helped to broker the licensing agreement.
"The group was attracted to Ei's topical expertise and valuable network of strategic partners to commercialize the assets."